The ReZoom™ Intraocular Lens is a true multifocal IOL. That means that it literally has multiple focal points so you can see well at a variety of distances. It allows most people to see well anywhere, be it near, intermediate or far. It is a second-generation refractive multifocal IOL that provides hyperopic cataract patients with greater independence from glasses than monofocal IOLs. The ReZoom™ proprietary multifocal design provides a range of vision that monofocals cannot match.
Full Range of Vision and Greater Independence from Glasses and Contact Lenses
Until recently, patients undergoing lens implant surgery received a monofocal, or single focus IOL. Monofocal IOLs implanted in both eyes generally provide excellent distance vision, while patients often need spectacle correction for near and intermediate vision. In the late 1990s, Advanced Medical Optics (AMO) introduced its first multifocal IOL designed to provide multiple points of focus, thereby dramatically reducing the need for bifocals or trifocal glasses after surgery.
Today, with its many optical design enhancements, AMO’s ReZoom™ Multifocal IOL is providing patients with a full range of vision and greater independence from glasses or contact lenses than ever before. Clinical studies show that 92% of those receiving the ReZoom™ Lens technology “never”, or “only occasionally”, need to wear glasses.
How does it work?
The ReZoom™ Balanced View Optics™ technology literally provides multiple focal points so you can see well at a variety of distances. The ReZoom™ Multifocal Lens has five uniquely proportioned visual zones designed to provide clear vision for different light and focal distances.
A visual side effect patients may experience is halos, or glare around lights, especially at night. The degree of these side effects varies from patient to patient and is most noticeable during the first few months after the procedure. For most people, these side effects diminish over time and do not impair your ability to function visually at night.
When is ReZoom™ used?
The ReZoom™ IOL is indicated for the visual correction of aphakia in persons 60 years of age or older in whom a cataractous lens has been removed and who may benefit from useful near vision without reading aids and increased spectacle independence across a range of distances.